The Chartis Group, a portfolio company of Riordan, Lewis & Haden, has been sold to Audax Private Equity
Lincoln worked closely with shareholders and management to find the right partner for the business to continue its growth trajectory. This was a global advisory engagement providing transaction expertise and managing the preparatory, marketing, negotiating, and diligence phases of the process.
The Chartis Group is a mission-based, values-driven firm and a leading provider of comprehensive advisory and analytics services to the healthcare industry. Since inception, the company’s unyielding mission has been to materially improve the delivery of healthcare in the world. Chartis provides a comprehensive, cross-functional approach to clients’ most pressing and complex needs that is unmatched in the industry and has firmly established the Company as a nationally recognized, premium brand.
Ken Graboys, CEO of Chartis commented, “Lincoln’s deep understanding of our unique business model and culture and senior-level dedication throughout the process were instrumental in achieving a successful outcome with the right partner that allows Chartis to continue its growth trajectory and help our clients achieve unrivaled results.”
Rob Zielinski, Partner at Riordan, Lewis & Haden, added, “Lincoln’s global platform and access to key decision makers were critical in securing an exceptional new long-term partner for Chartis.”
Lincoln’s execution expertise and partnership approach with management created a highly efficient process, resulting in a great outcome for Chartis’ shareholders and management team.
Meet our Senior Team
My goal is to inspire and motivate our people to make a true impact with their clients, their colleagues and their communities.
Managing Director | CEO North AmericaChicago
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical